S.No. |
Title |
Source Title |
Authors |
DOI |
Citing Works Count |
1 |
A Self-administered Version of the Functioning Assessment Short Test for Use in Population-based Studies: A Pilot Study
|
Clinical Practice And Epidemiology In Mental Health : CP & EMH
|
Christoph Riegler; Silke Wiedmann; Viktoria Rücker; Henning Teismann; Klaus Berger; Stefan Störk; Eduard Vieta; Hermann Faller; Bernhard T. Baune; Peter U. Heuschmann
|
10.2174/1745017902016010192
|
0
|
2 |
Tacrolimus - Pharmacokinetic Considerations for Clinicians.
|
Current Drug Metabolism
|
Katharina Schütte-Nütgen; Gerold Thölking; Barbara Suwelack; Stefan Reuter
|
10.2174/1389200219666180101104159
|
23
|
3 |
The Rule of Histology in the Diagnosis of Periprosthetic Infection: Specific Granulocyte Counting Methods and New Immunohistologic Staining Techniques may Increase the Diagnostic Value
|
The Open Orthopaedics Journal
|
Friedrich Boettner; Gabriele Koehler; Alexander Wegner; Tom Schmidt-Braekling; Georg Gosheger; Christian Goetze
|
10.2174/1874325001610010457
|
8
|
4 |
Prognostic Implications of Immunohistochemical Biomarkers in Non-Muscle-Invasive Bladder Cancer and Muscle-Invasive Bladder Cancer
|
Mini-reviews In Medicinal Chemistry
|
Martin Boegemann; Laura-Maria Krabbe
|
|
6
|
5 |
Polysaccharides as Bacterial Antiadhesive Agents and "Smart" Constituents for Improved Drug Delivery Systems Against Helicobacter pylori Infection.
|
Current Pharmaceutical Design
|
Bianca Menchicchi; Andreas Hensel; Francisco M. Goycoolea
|
10.2174/1381612821666150820104028
|
13
|
6 |
Heparan Sulphate as a Regulator of Leukocyte Recruitment in Inflammation
|
Current Protein & Peptide Science
|
Archana Kumar; Sampath Kumar Katakam; Ann-Kathrin Urbanowitz; Martin Götte
|
10.2174/1573402111666150213165054
|
36
|
7 |
The Role of Transcription Factors in the Formation of an Arrhythmogenic Substrate in Congestive Human Heart Failure
|
Current Medicinal Chemistry
|
Jan S. Schulte; Matthias D. Seidl; Frank U. Müller
|
10.2174/09298673113209990172
|
1
|
8 |
Differences in saccadic eye movements in subjects at high and low risk for panic disorder.
|
Current Pharmaceutical Design
|
Peter Zwanzger; Jacques Bradwejn; Julia Diemer; Roger W. Marshall; Diana Koszycki
|
10.2174/138161212803530934
|
3
|
9 |
Immune Therapy of Multiple Sclerosis - Future Strategies
|
Current Pharmaceutical Design
|
Sven G. Meuth; Kerstin Göbel; Heinz Wiendl
|
10.2174/138161212802502198
|
22
|
10 |
Exploiting the properties of biomolecules for brain targeting of nanoparticulate systems.
|
Current Medicinal Chemistry
|
Sandra Cramer; Ralf Rempe; Hans-Joachim Galla
|
10.2174/092986712800784711
|
10
|
11 |
The Potential of Secondary Metabolites from Plants as Drugs or Leads Against Protozoan Neglected Diseases - Part II
|
Current Medicinal Chemistry
|
Thomas J. Schmidt; Sami A. Khalid; Alvaro J. Romanha; T. Ma. Alves; Maique W. Biavatti; Reto Brun; FB Da Costa; S. L. De Castro; Vitor F. Ferreira; M. V. G. de Lacerda; João Henrique G. Lago; L. L. Leon; Norberto Peporine Lopes; R. C. das Ne
|
10.2174/092986712800229023
|
176
|
12 |
Emerging Treatment Strategies and Potential Therapeutic Targets in Primary Sjogrens Syndrome
|
Inflammation & Allergy Drug Targets
|
H. Becker; Hermann Pavenstaedt; P. Willeke
|
10.2174/187152810791292935
|
11
|
13 |
Multiple roles of the extracellular matrix in inflammation.
|
Current Pharmaceutical Design
|
Eva Korpos; Chuan Wu; Lydia Sorokin
|
10.2174/138161209787846685
|
71
|
14 |
GABAergic and endocannabinoid dysfunction in anxiety - future therapeutic targets?
|
Current Pharmaceutical Design
|
Katharina Domschke; Peter Zwanzger
|
10.2174/138161208786848784
|
37
|
15 |
Allelic Imbalances of the egfr Gene as Key Events in Breast Cancer Progression – the Concept of Committed Progenitor Cells
|
Current Cancer Drug Targets
|
Konstantin Agelopoulos; H. Buerger; B. Brandt
|
10.2174/156800908785133213
|
19
|
16 |
Targeted therapies in breast cancer: established drugs and recent developments.
|
Current Clinical Pharmacology
|
Jeanett Fischgräbe; Pia Wülfing
|
10.2174/157488408784293732
|
23
|
17 |
Generation of fusion proteins for selective occlusion of tumor vessels.
|
Current Drug Discovery Technologies
|
Rolf M. Mesters; Torsten Kessler; Christian Schwöppe; Ruediger Liersch; Christoph Schliemann; Heike Hintelmann; Ralf Bieker; Wolfgang E. Berdel
|
10.2174/157016308783769487
|
30
|
18 |
Preclinical testing of drug-induced proarrhythmia: value of transgenic models.
|
Cardiovascular & Hematological Agents In Medicinal Chemistry
|
Larissa Fabritz; G. Breithardt; Paulus Kirchhof
|
10.2174/187152507782109881
|
4
|
19 |
The endothelin axis: a novel target for pharmacotherapy of female malignancies.
|
Current Vascular Pharmacology
|
M. Smollich; Pia Wülfing
|
10.2174/157016107781024082
|
41
|
20 |
Vascular Endothelial Growth Factor and Its Receptor as Drug Targets in Hematological Malignancies
|
Current Drug Targets
|
Torsten Kessler; Frauke Fehrmann; Ralf Bieker; Wolfgang E. Berdel; Rolf M. Mesters
|
10.2174/138945007779940089
|
44
|
21 |
Oncogenic signaling in acute myeloid leukemia.
|
Current Drug Targets
|
Christian Brandts; Wolfgang E. Berdel; Hubert Serve
|
10.2174/138945007779940197
|
10
|
22 |
Recently Patented Applications of Homologous Cellular and Extracellular Agents as Therapeutics or Targets for the Prevention of Restenosis Post- Angioplasty
|
Recent Patents On Cardiovascular Drug Discovery
|
Rainer Klocke; Lekbira Hasib; Sigrid Nikol
|
10.2174/157489006775244272
|
5
|
23 |
Soluble paramagnetic chelates and stabilized colloidal particle solutions of iron oxides as contrast agents for magnetic resonance imaging.
|
Current Medicinal Chemistry
|
Bernd Tombach; Peter Reimer
|
10.2174/092986705774462932
|
4
|
24 |
Epileptogenicity and epileptic activity: mechanisms in an invertebrate model nervous system.
|
Current Drug Targets
|
U. Altrup
|
10.2174/1389450043345344
|
9
|
25 |
Regulation of the immune response by natural IgM: lessons from warm autoimmune hemolytic anemia.
|
Current Pharmaceutical Design
|
Dorothea Stahl; Walter Sibrowski
|
10.2174/1381612033454397
|
8
|